Streetbeat News

Stock Prices

LI

NDSN

PANW

WIX

ZM

U.S. stock futures are trading higher this Monday. Key stocks to watch include Li Auto, Zoom Video, Wix.com, Nordson Corporation, and Palo Alto Networks, all of which have upcoming earnings reports or have posted recent results.

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 6:00 am

GME

NDSN

PANW

ZM

Investor optimism improved as the Dow Jones index settled above 40,000 for the first time, with the S&P 500 also recording gains. GameStop Corp (NYSE:GME) shares fell 20% after releasing preliminary first-quarter results. Investors are awaiting earnings results from Nordson Corporation (NASDAQ:NDSN), Palo Alto Networks, Inc. (NASDAQ:PANW), and Zoom Video Communications, Inc. (NASDAQ:ZM).

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 5:59 am

GILD

Gilead Sciences announced that their investigational drug Seladelpar shows significant improvements in liver disease progression and itch reduction in primary biliary cholangitis. 70% of patients receiving Seladelpar 10mg achieved a clinically meaningful composite endpoint, and 37% achieved ALP normalization at 12 months. The reduction in patient-reported pruritus was rapid and durable.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 5:59 am

BSX

Boston Scientific's mCRM System, including the EMPOWER LP pacemaker and EMBLEM S-ICD System, has met all six-month safety and efficacy endpoints in the MODULAR ATP study. Key findings include a 97.5% major complication-free rate, 98.8% communication success rate, and 61.3% ATP success rate.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 5:55 am

DYN

Dyne Therapeutics (NASDAQ:DYN) announced it will unveil new clinical data from its Phase 1/2 ACHIEVE and DELIVER trials on May 20, 2024, during a virtual event. This is an update to their previous guidance for the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 5:48 am

SVRA

Savara Inc. and Trillium Health LLC presented new data on autoimmune pulmonary alveolar proteinosis (PAP) at ATS 2024. Savara's data highlighted the significant healthcare burden of PAP, while Trillium introduced a novel test for detecting GM-CSF antibodies to aid in diagnosing aPAP.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 5:46 am

AAPL

Renowned analyst Ming-Chi Kuo predicts that Apple Inc. (NASDAQ:AAPL) will introduce new color options for its iPhone 16 Pro models, replacing the 'Blue Titanium' with 'Rose Titanium'. The iPhone 16 and 16 Plus will also see a color change, with 'pale yellow' being replaced by 'white'. The iPhone 16 series is expected to launch in the fall of 2024 with larger screens, a revamped design, and improved performance.

Portfolio Pulse from Ananya Gairola

May 20, 2024 | 5:29 am

NVDA

Nvidia's journey from near bankruptcy to a $2 trillion valuation was significantly influenced by a $5 million lifeline from a former Sega executive, Shoichiro Irimajiri. This act of kindness allowed Nvidia to develop a breakthrough chip and go public in 1999. However, Nvidia now faces competition from Qualcomm, Ampere Computing, and AMD in the AI-focused server market.

Portfolio Pulse from Benzinga Neuro

May 20, 2024 | 5:13 am

WIX

Wix.com (NASDAQ:WIX) reported Q1 2024 earnings of $1.29 per share, beating the analyst estimate of $1.03 by 25.24%. Sales were $419.776 million, surpassing the $417.837 million estimate. This represents a 41.76% increase in EPS and a 12.22% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 5:02 am

AMGN

AZN

AstraZeneca and Amgen's TEZSPIRE shows potential for future COPD treatment based on new data from the Phase IIa COURSE trial presented at ATS 2024. The trial results indicate a 17% reduction in COPD exacerbations, with more significant reductions in patients with higher eosinophil levels.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 4:55 am